Trazodone is not an antipsychotic. It is classified as an antidepressant, specifically a phenylpiperazine antidepressant in the category known as serotonin antagonist and reuptake inhibitors (SARIs). The FDA label describes it as “an antidepressant chemically unrelated to tricyclic, tetracyclic, or other known antidepressant agents.” The confusion is understandable, though, because trazodone shares one receptor-blocking action with some atypical antipsychotics, and it’s often prescribed for sleep rather than depression, which can make its identity feel unclear.
Why Trazodone Gets Confused With Antipsychotics
Part of the confusion comes from how trazodone works in the brain. It blocks a specific serotonin receptor called 5-HT2A, and this same receptor is also blocked by several atypical antipsychotics. That overlapping mechanism can make the two drug classes look similar on paper. Trazodone also causes sedation, which people sometimes associate with antipsychotic medications.
Another reason for the mix-up: trazodone is sometimes prescribed alongside antipsychotics in psychiatric treatment plans, or used in similar clinical settings like inpatient units. When patients see it on their medication list next to drugs they know are antipsychotics, the assumption is natural.
How Trazodone Actually Works
Trazodone’s antidepressant effect comes primarily from blocking the reuptake of serotonin, which keeps more serotonin available in the brain. It also blocks 5-HT2A/2C serotonin receptors and has activity at histamine (H1) and alpha-1 adrenergic receptors. That combination of receptor actions is what makes it a SARI rather than a standard SSRI like sertraline or fluoxetine.
At low doses, between 25 and 100 mg, the sedating effects dominate. The serotonin receptor blockade and histamine receptor blockade at these doses produce drowsiness without much antidepressant benefit. This is why low-dose trazodone is so commonly used as a sleep aid. At higher doses, from 150 to 600 mg, the serotonin reuptake inhibition becomes more prominent, and that’s where the antidepressant effect kicks in. Most people who take trazodone for sleep never reach the doses needed for depression treatment.
After you take it, trazodone reaches peak levels in about one hour on an empty stomach, or two hours with food. Its half-life ranges from about 3 to 9 hours, which is why its sedating effect wears off by morning for most people.
How Antipsychotics Differ
The defining feature of all antipsychotic medications is their ability to block dopamine D2 receptors in the brain. This dopamine-blocking action is what treats the hallucinations, delusions, and disordered thinking that characterize psychosis. Every antipsychotic on the market, whether older “typical” versions or newer “atypical” ones, shares this core mechanism. The degree of D2 receptor blockade is considered the key therapeutic action for reducing psychotic symptoms.
Trazodone does not meaningfully block dopamine D2 receptors. It works on serotonin pathways instead. This is a fundamental pharmacological difference, not a technicality. A drug that doesn’t block dopamine D2 receptors cannot treat psychosis in the way antipsychotics do.
The side effect profiles reflect this difference clearly. Atypical antipsychotics like olanzapine carry significant risks of weight gain, increased appetite, elevated blood sugar, and cholesterol changes. In user-reported data, 37% of olanzapine users experienced weight gain. Trazodone does not carry these metabolic side effects. Its side effect profile looks quite different from the antipsychotic class.
What Trazodone Is Prescribed For
Trazodone is FDA-approved for treating major depressive disorder. In practice, though, it is prescribed far more often for insomnia than for depression. The low-dose sedating effect (25 to 100 mg) has made it one of the most commonly prescribed sleep medications in the United States, partly because it doesn’t carry the dependence risk associated with benzodiazepines or other controlled sleep aids.
For depression, the effective dose range is 150 to 600 mg, but these higher doses increase side effects like orthostatic hypotension (a drop in blood pressure when standing up) and excessive sedation, which limits how well many people tolerate it. This is one reason trazodone has largely shifted in clinical practice from a first-line antidepressant to a preferred sleep aid.
Side Effects to Know About
The most common side effect is drowsiness, which is the whole point when it’s prescribed for sleep but can be a problem during the day. Orthostatic hypotension is another frequent issue, especially at higher doses. You may feel lightheaded or dizzy when getting up quickly.
Trazodone carries a rare but serious risk of priapism, a prolonged and painful erection that requires emergency treatment. The incidence is low, roughly 1.5 per 100,000 person-years overall and 2.9 per 100,000 in men over 40. It’s rare, but it’s a medical emergency if it happens.
There is also a cardiac concern. Trazodone can prolong the QT interval, a measure of electrical activity in the heart, which increases the risk of dangerous heart rhythm problems. This effect has been documented both at prescribed doses and in overdose situations. If you have a history of heart rhythm issues, this is something your prescriber should know about before starting the medication.
Interestingly, about half of all medication-induced priapism cases overall are caused by antipsychotic drugs rather than trazodone. This is another point where the two drug classes sometimes get grouped together in patient information, reinforcing the misconception that trazodone belongs in the antipsychotic category.